WA AND QLD RSV IMMUNISATION PROGRAMS SHOW SIGNIFICANT REDUCTION IN INFANT HOSPITALISATIONS Consumer and HCP awareness, advocacy focus until national program decision is reversed
Filmed Perth, Western Australia | October 2024
RSV is the number one cause of hospitalisation of Australian children under five years of age, according to the Immunisation Foundation of Australia (IFA). There are mounting concerns that Australians at greatest risk of severe Respiratory Syncytial Virus, or RSV will miss out on protection against the lung infection, with the Federal Government failing to commit to a national RSV immunisation program.
Associate Professor Hannah Moore OAM, Program Head of Infections and Vaccines at the Kids Research Institute Australia, met with Australian Health Journal to discuss the impact of Respiratory Syncytial Virus (RSV) on children and immunisation showing evidence of a significant reduction in hospitalisations.
She talks about RSV causing chest infections in babies and adults, with most children being infected by the age of three. However, certain groups face higher disease rates, and infants under six months are particularly vulnerable, with up to one in 30 being hospitalised. Even older children up to five years old experience hospitalisation rates for RSV around one in 500 children.
Australian Health Journal also spoke with Catherine Hughes, the Founder and Executive Director of the Immunisation Foundation of Australia (IFA), on the need for RSV immunisations to be included in the National Immunisation Plan to ensure equitable access for vulnerable Australians. RSV immunisation programs in Western Australia and Queensland are showing promising results, leading to a significant reduction in hospitalisations. This is in contrast with the disappointment in the PBAC recently rejecting a national RSV vaccine push.
“Australia urgently needs a nationwide RSV immunisation program,” said Catherine Hughes AM, Founder and Director of the Immunisation Foundation of Australia.
IFA aims to raise awareness of RSV severity and has launched the “Unite Against RSV” campaign to provide resources for the clinical community and families. Additionally, vaccines for adults over 60 and pregnant women, as well as antibody therapy for infants, have been approved to combat RSV. The Foundation also provides regular updates on policy changes related to RSV to clinicians and other providers through its website and email subscriptions.
Efforts are being made to ensure that all Australians, especially vulnerable individuals, have access to affordable RSV immunisations. The Foundation’s advocacy work aims to include RSV immunisations on the National Immunisation Plan to guarantee easy access for all Australian families. The success of RSV immunisation programs in Western Australia and Queensland mounts the evidence on the positive impact of proactive measures in combating RSV.
-
Cost of living relief for students training in national skills shortage fields
The Australian Government is expanding the Commonwealth Prac Payment to eligible students in 10 additional frontline allied health disciplines, providing financial support during mandatory university placements.
From 1 July 2027, eligible students studying audiology, pharmacy, radiography, clinical psychology, physiotherapy, rehabilitation therapies, occupational therapy, podiatry, speech pathology and paramedicine will be able to access the payment.
-
The desire for primary care nurses to do more, be recognised and valued for the work they do
Denise Lyons is a highly experienced nurse with over 40 years in the profession, including more than 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centred care that improves the health and wellbeing of her community.
-
Retaining a clinical perspective in macro level changes
Dr Shona Sundaraj BAppSc (Phty), MBBS, FRACGP, MBA is Group Medical Director at Medibank, bringing over two decades of clinical and systems experience to strategy, research and stakeholder engagement. She leads the Medibank Better Health Research Hub and Chairs the Health Research Governance Committee, guiding stakeholder engagement, competitive grant rounds and partnerships with universities, translational research centres and peak bodies to support evidence based improvement in care.
